Ocular Therapeutix
Ocular Therapeutix develops transformational treatments to enhance vision and quality of life through sustainable drug delivery, focusing on retinal diseases, glaucoma, ocular surface diseases, and ophthalmic surgery.
Services
Ocular Therapeutix develops transformational treatments aimed at enhancing vision and quality of life through consistent and sustainable drug delivery. The company focuses on researching therapeutic areas such as retinal diseases, glaucoma, ocular surface diseases, and ophthalmic surgery. It engages in clinical trials to evaluate the safety and efficacy of its product candidates, contributing to advanced treatments in ophthalmology. Additionally, Ocular Therapeutix offers partnership opportunities to advance the standard of care in the field.
Products
Ocular Therapeutix offers a robust pipeline of ophthalmology products designed to address various ocular conditions. Key products include AXPAXLI™ (axitinib intravitreal implant), PAXTRAVA™ (travoprost intracameral implant), OTX-CSI (cyclosporine intracanalicular insert), and OTX-DED (dexamethasone intracanalicular insert). The company markets products like DEXTENZA® (dexamethasone ophthalmic insert) and ReSure® Sealant, which contribute to the company's mission of providing sustainable and effective treatments for eye diseases.
Technology
Ocular Therapeutix utilizes its proprietary ELUTYX™ Technology, a versatile platform that supports the creation of sustained-release therapies. This technology is designed to enhance the consistency and longevity of drug delivery for various ocular conditions, potentially expanding treatment options. The ELUTYX™ Technology plays a crucial role in the development of the company's pipeline products, aiming to offer innovative solutions in ophthalmology.
Therapeutic Areas
Ocular Therapeutix conducts extensive research in multiple therapeutic areas including retinal diseases, glaucoma, ocular surface diseases, and ophthalmic surgery. The company's focus on these areas allows it to address some of the most pressing needs in eye health, developing products that target specific conditions to improve patient outcomes. By prioritizing these therapeutic areas, Ocular Therapeutix aims to make significant strides in the field of ophthalmology.